| Literature DB >> 25276819 |
Jörg Friesenbichler1, Patrick Sadoghi1, Werner Maurer-Ertl1, Joanna Szkandera2, Mathias Glehr1, Kathrin Ogris3, Matthias Wolf1, Christian Weger1, Andreas Leithner1.
Abstract
The purpose of this study was to determine the concentrations of cobalt, chromium, and molybdenum in the serum of paediatric tumour patients after fixed hinge total knee arthroplasty. Further, these metal ion levels were compared with serum metal ion levels of patients with other orthopaedic devices such as hip and knee prostheses with metal-on-metal or metal-on-polyethylene articulation to find differences between anatomical locations, abrasion characteristics, and bearing surfaces. After an average follow-up of 108 months (range: 67 to 163) of 11 paediatric patients with fixed hinge total knee arthroplasty, the mean concentrations for Co and Cr were significantly increased while Mo was within the limits compared to the upper values from the reference laboratory. Furthermore, these serum concentrations were significantly higher compared to patients with a standard rotating hinge device (P = 0.002 and P < 0.001) and preoperative controls (P < 0.001). On the other hand, the serum levels of patients following MoM THA or rotating hinge arthroplasty using megaprostheses were higher. Therefore, periodic long-term follow-ups are recommended due to the rising concerns about systemic metal ion exposure in the literature. Upon the occurrence of adverse reactions to metal debris the revision of the fixed hinge implant should be considered.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25276819 PMCID: PMC4172978 DOI: 10.1155/2014/817257
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1The different devices under investigation: (a) HMRS, (b) LPS, (c) S-ROM Noiles, and (d) ASR XL Head.
Demographic data of the study population and mean metal ion levels in μg/L (range) in the different prosthesis groups. The P value indicates differences between several implant groups compared to the fixed hinge group. Furthermore, correlations between Co and Cr levels in the implant groups as well as metal ion concentrations and follow-up are shown (THA: total hip arthroplasty; RHK: rotating hinge knee arthroplasty; yr/yrs: year/years; mths: months; FU: follow-up).
| Fixed hinge prostheses ( | Preoperative THA ( | MoM THA 1 yr ( | MoM THA 2 yrs ( | Standard RHK ( | Megaprostheses RHK ( | |
|---|---|---|---|---|---|---|
| Mean age (yrs) | 14 (10 to 23) | 52 (40 to 61) | n.a. | n.a. | 73 (60 to 81) | 49 (15 to 83) |
| Sex ratio (m : f) | 9 : 2 | 17 : 15 | 17 : 15 | 17 : 15 | 4 : 4 | 12 : 5 |
| Mean follow-up (mths) | 108 (67 to 163) | n.a. | 12 (12 to 12) | 24 (24 to 24) | 37 (15 to 62) | 34 (9 to 67) |
| Co serum ( | 4.7 (0.4 to 12.8) | 0.3 (0 to 5.4) | 6.0 (0 to 58.5) | 9.3 (0.3 to 78.2) | 0.3 (0 to 0.7) | 7.5 (0 to 47.0) |
| Cr serum ( | 4.01 (1.48 to 8.91) | 0.68 (0.07 to 7.53) | 5.86 (1.11 to 26.56) | 8.31 (0.71 to 51.98) | 0.33 (0.06 to 0.95) | 2.98 (0.12 to 24.90) |
|
| — | <0.001/<0.001 | 0.852/0.731 | 0.501/0.235 | 0.002/<0.001 | 0.312/0.002 |
| Correlation Co : Cr | 0.742 ( | 0.945 ( | 0.869 ( | 0.967 ( | 0.764 ( | 0.945 ( |
| Correlation Co : FU | 0.240 ( | x | x | x | 0.099 ( | 0.300 ( |
| Correlation Cr : FU | 0.137 ( | x | x | x | 0.007 ( | 0.373 ( |
Figure 2Box plot showing the cobalt and chromium serum metal ion levels in the fixed hinge megaprosthesis group in proportion to the other prostheses and the control group. Patients with fixed hinge devices had higher concentrations of Co and Cr in the plasma compared to preoperative controls and patients with a standard rotating hinge device. These differences reached a statistically significant difference (Table 1).
Figure 3(a) The femoral and (b) the tibial component of an explanted HMRS megaprosthesis. At the side of the hinge there is a direct metal-on-metal articulation clearly with signs of metal debris (scratches and striation).
Figure 4Intraoperative photograph at revision of a fixed hinge megaprosthesis in a 20-year-old male patient showing a marked metallosis in the periprosthetic soft tissues of the lower leg 119 months after implantation.